Professor Marc Pellegrini, page-3

The silence from BIT management is deafening!
Surely we must be due for an update?
Does BIT225 work or not?
I know that in medical science they can talk about a drug in many different ways, which makes it hard for a layman to understand whether they are talking about the same thing or not? what I want to know is our drug a good thing or not?

I found this in my travels which says it doesn't work?
https://www.researchgate.net/figure...-we-show-the-chemical-structure_fig1_40482779

). JK3/32 was also superior to a clinically progressed compound, BIT225 26,27 , which, in our hands, showed no antiviral activity discernible from effects upon cellular viability (figure S3). Thus, we propose that the favourable potency and selectivity index demonstrated by JK3/32 could serve as a high quality starting point for a more comprehensive p7-targeted inhibitor drug development programme. ...

Come on MM we deserve some sort of explanation I believe?